The acceptance of unfamiliar foods is influenced by how it relates to food that we would normally consume. We are somewhat programmed from early childhood to prefer familiar foods. Neophobia prevents us from consuming potentially harmful food by provoking an avoidant behaviour. Although this served our primitive ancestors well, this instinctive pickiness is no longer helpful in the transition to the novel, sustainable protein sources.

In order to achieve a more substantial food industry, consumers must make sustainable food choices. In our earlier Mycotalk “Why does the vegan industry make food look and taste like meat?” we discussed some of the things the individual consumer can do to be more open to vegan options. But how can the food industry contribute?

Consumers are becoming more aware of how unsustainable meat production currently is and the benefits of reducing meat consumption, from social, environmental, health and ethical perspectives. Yet, the key to making meat substitutes more attractive to consumers is to significantly improve sensory qualities and the resemblance of meat, not just informing of the benefits. One stand-out reason that makes it difficult to get wider acceptance of meat substitutes, is their sensory characteristics. It is a challenge to develop new foods that are attractive to consumers in general, but even more complex when it is meant to replace a highly appreciated product such as meat. It is essential to attract new consumers to accelerate the transition into eating less meat.

In addition to the fear of new foods, many consumers have a fear of processed foods. There are many misconceptions regarding what is natural and what is processed. “Natural” is often automatically perceived as healthy and “processed” as unhealthy or unsafe. Whereas in reality many of the ‘processes’ are actually used to make the food healthier or safer.

Virtually all foods go through processing, for example, heating, which is one of the most common processing steps. In order to transform the protein landscape, we must adapt to and accept new technologies and processes, to be able to produce and consume the future of food. If we take a look at fermented foods, where microorganisms are used in ‘processing’, many appreciated food and drinks such as kombucha, apple cider vinegar, tempeh, kimchi and wine all fall into the category of “processed”, and they are often considered both ‘natural’ and healthy.

Mycoprotein is no novelty on the consumer market, many efforts have previously been made by manufacturers to improve the image of meat substitutes. Mycoprotein for food use has been approved in the UK for around 40 years and in the US for the past 20 years. So, although many new products are popping up in the field of mycoproteins, the technology and the product category has been around for quite some time already and should in theory not even be considered new anymore. Perhaps we can agree then, that mycoprotein should join the club of well-known items that are often referred to as being ‘natural’ like sourdough bread, yoghurt or almond milk that are per se processed, but not necessarily unhealthy. Again, it is all about consumer perception and sometimes, time and exposure are needed for this to change.

In the food industry, one of the best things we can do to nudge people in the direction of sustainable meat substitutes is to make it feel as familiar as possible, by offering great appearance, smell, taste and texture. This is something we are working on every day at Mycorena, making vegan versions of your favourite foods that feel and taste familiar, without compromise! As far as processing goes, let’s change the perception of only ‘natural’ and ‘non-processed’ foods equal healthy foods, once and for all.

Towards DeFi and Beyond 

About Polis 

You can begin sending emails in mass with our exceptionally streamlined BulkMailVPS servers which can support your business benefit. We will set up an SMTP server for you with online mailing software which permits you to follow your campaigns opens, ricochets, withdraw.

BULKMAILVPS the offer gave IP servers with mass email advancing programming that offers boundless contacts for each record. Other Bulk Email Services would confine you to the number of interfaces you can have in your record. You can have an undefined number of contacts in your summaries from what you need, there is no restriction.

Bulk mail VPS enhance you with everything that you require for your email marketing services. You'll have everything leveled out with the help of various methods and techniques and tools that we could offer at a genuinely moderate expense. 

The best thing with BULKMAILVPS is that while sending the email battle you doesn't require any framework, specialized aptitude to utilize our mass email programming, in actuality our product will spare your valuable time and cash. Besides, with BULKMAILVPS you will have the option to spare the set-up cost as we give free every minute of every day specialized help and our product is easy to understand so discharge every one of your stresses when we are with you.

This report provides an analysis of the global Electric Vehicle Charging Station market for the period of 2016 to 2027, wherein the period from 2020 to 2027 comprises the forecast period and 2019 is the base year. Data for 2018 is provided as historical information. The report covers all the major trends and technologies playing a major role in the growth of the Electric Vehicle Charging Station market over the forecast period. It also highlights various drivers, restraints and opportunities expected to influence the market’s growth during the forecast period. The study provides a holistic perspective on the market’s growth in terms of revenue in US$ Mn, across different geographical regions namely North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Get the Sample Copy of Report, Click Here@ https://www.precedenceresearch.com/sample/1003 

Scope of the Report

The market overview section of the report showcases the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this market. The report also provides value chain analysis and key market indicators for the Electric Vehicle Charging Station market. The Electric Vehicle Charging Station market estimates are the result of our in-depth secondary research, primary interviews and in-house expert panel reviews. These market estimates have been analyzed by taking into account the impact of different political, social, economic, technological and legal factors along with the current market dynamics affecting the market growth.

Segmentation

The global Electric Vehicle Charging Station market is segmented on the basis of type, application, regions and others. Electric Vehicle Charging Station market is also segmented on the basis of regions into North America, South America, Europe, Asia Pacific, and Middle East & Africa. The report covers the analysis of these segments across all geographies, along with qualitative analysis for key market indicators supplementing the growth of Electric Vehicle Charging Station market during the forecast period.

By Charging Station Type

• AC Charging
• DC Charging
• Wireless Charging

By Power Output

• <11KW
• 11KW-50KW
• >50KW

By Supplier Type

• OE Charging Station
• Private Charging Station

By End User

• Private Type
• Public Type

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of the World

Get Customization on This Report@ https://www.precedenceresearch.com/customization/1003 

Competitive Dynamics

The report also includes competitive profiling of the key players associated with the Electric Vehicle Charging Station market around the globe. The important business strategies adopted by them, their market positioning, financials, SWOT analysis and recent developments have also been identified in the research report. The competitive landscape section of the report also gives an overview about the major contributing regions/countries by these key players in order to strengthen their market position in the future.

Technology advancement and rising medical application in 3D printing across emerging economies, are forcing companies to develop Electric Vehicle Charging Station to continue the profitability of the market.

• ABB Ltd.

• ChargePoint, Inc.

• EVgo Services LLC.

• Allego

• Scheinder Electric

• Blink Charging Co.

• Wi Tricity Corporation

• Toshiba Corporation

• AeroViroment, Inc.

• Mojo Mobility, Inc.

• General Electric

• Robert Bosch GmbH

• Chargemaster plc.

• Evatran Group

• HellaKGaAHueck& Co.

• Siemens AG

• Leviton Manufacturing Co., Inc.

• Efacec

• Alfen N.V.

• Denso Corporation

• Elix Wireless

• Tesla Inc.

• ClipperCreek

• Engie

• Infineon Technologies AG

• Qualcomm Technologies, Inc.

Get Full Access of This Research Report@ https://www.precedenceresearch.com/checkout/1003 

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Electric Vehicle Charging Station Market, By Charging Station

7.1. Electric Vehicle Charging Station Market, by Charging Station Type, 2020-2027
7.1.1. AC Charging
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. DC Charging
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Wireless Charging
7.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Electric Vehicle Charging Station Market, By Power Output

8.1. Electric Vehicle Charging Station Market, by Power Output, 2020-2027
8.1.1. <11KW
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. 11KW-50KW
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. >50KW
8.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Electric Vehicle Charging Station Market, By Supplier Type

9.1. Electric Vehicle Charging Station Market, by Supplier Type, 2020-2027
9.1.1. OE Charging Station
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Private Charging Station
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Electric Vehicle Charging Station Market, By End User

10.1. Electric Vehicle Charging Station Market, by End User, 2020-2027
10.1.1. Private Type
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Public Type
10.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Electric Vehicle Charging Station Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.1.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.1.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.2.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.2.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.3.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.3.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.4.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.4.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.5.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.5.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Charging Station (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Power Output (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Supplier Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)

Chapter 12. Company Profiles

12.1. ABB Ltd.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. ChargePoint, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. EVgo Services LLC.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Allego
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Scheinder Electric
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Blink Charging Co.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Wi Tricity Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Toshiba Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. AeroViroment, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Mojo Mobility, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. General Electric
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Robert Bosch GmbH
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Chargemaster plc.
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Evatran Group
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. HellaKGaAHueck& Co.
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
12.16. Siemens AG
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance
12.16.4. Recent Initiatives
12.17. Leviton Manufacturing Co., Inc.
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance
12.17.4. Recent Initiatives
12.18. Efacec
12.18.1. Company Overview
12.18.2. Product Offerings
12.18.3. Financial Performance
12.18.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

 Get Full Access of This Research Report@ https://www.precedenceresearch.com/checkout/1003 

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace amp; defense, among different ventures present globally. We endeavor to give our clients latest insights on upcoming technologies, new developing markets, dynamically changing business conditions and most recent business-driven applications. These insights help our clients to take informed decisions for their business growth.

Contact Us

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Follow Us

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/Precedence-Research-105885977867944

https://twitter.com/PrecedenceR

"Relapsed and refractory multiple myeloma is a life-threatening disease with limited treatment alternatives in later stages. A clinical trial may offer patients new treatment options. The pandemic has had a major impact on clinical trial activities with many of them closed to recruitment or halted. As the general situation now is improving, clinical trials can be re-initiated in regions where the potential risk-benefit for the patient is positive", says Luděk Pour, MD, PhD, Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Czech Republic.

Patient enrollment will start as soon as possible in the following studies; the ANCHOR combination study, the BRIDGE study and the AL Amyloidosis study.  The LIGHTHOUSE combination study will start after the summer. Oncopeptides will provide updated guidance on timelines, once the studies have been reinitiated.

"I am really pleased that despite the ongoing pandemic we can restart our clinical program for melflufen in a safe and responsible way," says Klaas Bakker, MD, PhD, Chief Medical Officer of Oncopeptides. "There is a significant unmet medical need of new therapies for patients with relapsed refractory multiple myeloma who in several cases not have any treatment options left. Also, I am very pleased to be able to continue the AL amyloidosis study, where the unmet medical need is particularly high".

The information in the Press Release is information that Oncopeptides is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person above, on May 28, 2020 at 08.00 (CET).

About melflufen

Melflufen (melphalan flufenamide) is a first-in-class anti-cancer peptide-drug conjugate that rapidly delivers an alkylating payload into tumor cells. Melflufen is rapidly taken up by myeloma cells due to its high lipophilicity and is immediately cleaved by peptidases to deliver an entrapped hydrophilic alkylator payload. Peptidases play a key role in protein homeostasis and feature in cellular processes such as cell-cycle progression and programmed cell death. In vitro, melflufen is 50-fold more potent in myeloma cells than the alkylator payload itself due to the increased intracellular alkylator concentration.

Melflufen displays cytotoxic activity against myeloma cell lines resistant to other treatments, including alkylators, and has also demonstrated inhibition of DNA repair induction and angiogenesis in preclinical studies.

About Oncopeptides

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen, a first-in-class anti-cancer peptide-drug conjugate that rapidly delivers an alkylating payload into tumor cells. Melflufen (melphalan flufenamide) is in development as a new treatment for the hematological cancer multiple myeloma and is currently being evaluated in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Oncopeptides' headquarters is in Stockholm, Sweden with U.S. headquarters in Boston, Mass. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO.

For more information, please contact:

Source

https://www.prnewswire.com/news-releases/oncopeptides-reinitiates-patient-enrollment-to-the-melflufen-clinical-program-following-a-temporary-pause-due-to-the-covid-19-pandemic-301066742.html